Atlas Trials

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

Clinical trial NCT00001582 · COMPLETED

Trial details

NCT number
NCT00001582
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Study type
OBSERVATIONAL
T-cell LymphomaB-Cell LymphomaATLMyeloma
Start date
1997-06-07
Primary completion
2023-03-17
Enrollment
902

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.